| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |